Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Carcinoma to the Uterine Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05468190
What this trial is testing

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Looking for participantsNCT06670911
What this trial is testing

Low-dose Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer.

Who this might be right for
Persistent, Recurrent, or Metastatic Cervical Cancer
Instituto Nacional de Cancer, Brazil 44
Testing effectiveness (Phase 2)UnknownNCT04641728
What this trial is testing

Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Saitama Medical University International Medical Center 28
Not applicableNot Yet RecruitingNCT06150222
What this trial is testing

Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study

Who this might be right for
Cancer, CervicalRecurrenceMetastasis
Erasmus Medical Center 350
Early research (Phase 1)Study completedNCT00003377
What this trial is testing

Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT07230626
What this trial is testing

SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 412
Large-scale testing (Phase 3)WithdrawnNCT04943627
What this trial is testing

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

Who this might be right for
Advanced CancerMetastatic Cervical Cancer
Agenus Inc.
Not applicableNot Yet RecruitingNCT06155422
What this trial is testing

A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Gang Chen (101199) 670
Large-scale testing (Phase 3)Looking for participantsNCT07472153
What this trial is testing

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Who this might be right for
Metastatic Cervical CancerPersistent Cervical CancerRecurrent Cervical Cancer
N.N. Alexandrov National Cancer Centre 120
Testing effectiveness (Phase 2)Looking for participantsNCT07054567
What this trial is testing

BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 96
Large-scale testing (Phase 3)Enrolling By InvitationNCT06755515
What this trial is testing

A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Shandong New Time Pharmaceutical Co., LTD 510
Testing effectiveness (Phase 2)Ended earlyNCT03644342
What this trial is testing

Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix

Who this might be right for
Metastatic Carcinoma of the Cervix
Michelle S Ludwig 4
Testing effectiveness (Phase 2)Study completedNCT00807079
What this trial is testing

Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
ARCAGY/ GINECO GROUP 12
Testing effectiveness (Phase 2)Ended earlyNCT00782041
What this trial is testing

Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer

Who this might be right for
Uterine Neoplasms
Sanofi 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07143292
What this trial is testing

A Prospective, Randomized, Parallel Trial of Famitinib Malate at Different Doses Combined With Camrelizumab for the Treatment of Recurrent and Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer MetastaticCervical Cancer Recurrent
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06882447
What this trial is testing

QL1706 Combined with Nine HPV Vaccine As First-line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer Stage IVB
Northern Jiangsu People's Hospital 35
Testing effectiveness (Phase 2)UnknownNCT05137171
What this trial is testing

AK105 Combined With Anlotinib in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
The First Affiliated Hospital of Zhengzhou University 36
Early research (Phase 1)UnknownNCT05895370
What this trial is testing

HPV-T in HPV-16 Positive Recurrent or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
BGI, China 12
Early research (Phase 1)Not Yet RecruitingNCT06383507
What this trial is testing

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+4 more
Zhejiang University 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07141186
What this trial is testing

QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy

Who this might be right for
Cervical CancerCervical Cancer MetastaticCervical Cancer Recurrent+2 more
Tianjin Medical University Cancer Institute and Hospital 50
Next Page